Project Grant R01EB038287
- Federal Grant Award Summary The University of Missouri System received a $418,043 Project Grant from the National Institute of Biomedical Imaging and Bioengineering under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), awarded August 1, 2025, with completion targeted for July 31, 2027. This award supports the design and development of a self-tunable messenger RNA (mRNA) gene circuit engineered to achieve sustained, precise control...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded The Leland Stanford Junior University a $127,926 Project Grant (CFDA 93.286: Discovery and Applied Research for Technological Innovations to Improve Human Health) beginning August 1, 2025 and concluding July 31, 2027. The grant supports the development of a subdermal, implantable monitoring platform designed to detect heart attacks and monitor heart failure progression through continuous...
- The National Science Foundation (NSF) awarded a $550,000 Project Grant under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) to the University of Missouri System to develop six-lead, wearable heart monitors using innovative, multifunctional, porous, soft materials. The project aims to enhance wearable heart monitors for improved cardiac health management by addressing current limitations in ambulatory ECG monitoring, such as motion-induced artifacts and limited...
- Federal Project Grant Award Summary The University of Missouri System received a $479,716 Project Grant from the National Science Foundation's Engineering program (CFDA 47.041) awarded on October 1, 2025, with a completion date of May 31, 2028. This award supports the development of soft bio-ionic transistors designed to measure and analyze ionic characteristics of biological cells and their environments. The primary deliverable is innovative soft ionic transistor technology that bridges rigid...
- Federal Grant Award Summary The University of Michigan received a $149,264 Project Grant awarded on March 26, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) administered by the National Institute of Biomedical Imaging and Bioengineering. The grant supports development of innovative magnetic resonance fingerprinting (MRF) technology optimized for cardiac magnetic resonance imaging (MRI) in patients with cardiac...
- Federal Grant Award Summary Funding Agency and Program: National Institute of Biomedical Imaging and Bioengineering (NIBIB), Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) Award Details: Texas A&M Engineering Experiment Station received a $395,695 Project Grant award effective August 1, 2025, with a completion date of July 31, 2029, to develop novel multi-modal ultrasound imaging methods for non-invasive monitoring and prediction of...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded Illinois Institute of Technology a $1,189,782 Project Grant effective July 1, 2025, through March 31, 2029, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award supports the development and clinical validation of domain-aware anthropomorphic model observers (AMO)—deep learning systems designed to replace human...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded $435,372 to the University of Nebraska Medical Center (UNMC) on August 13, 2025, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The project, which concludes July 31, 2027, focuses on developing a novel electrotaxis system to enhance chronic wound healing. The research addresses a critical clinical need by leveraging...
- Federal Project Grant Award Summary George Washington University received a $664,432 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 1, 2025, through May 31, 2029. The award supports the development of a wireless, soft, implantable platform for in vivo cardiac calcium-voltage mapping and pacing in small animal models. The deliverable comprises three integrated components: a...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded University of California, Berkeley a $641,360 Project Grant effective July 1, 2025, through May 31, 2029, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). This award funds development and validation of a novel distributed active programmable transmit (ADAPT) coil technology designed to advance radiofrequency (RF)...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded the University of Missouri System a $597,977 Project Grant on March 11, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award supports the development of multimodal, porous, starfish-like soft wearable bioelectronic systems designed to enable continuous, motion-artifact-resilient cardiac monitoring. The research addresses critical limitations in existing cardiac monitoring devices by integrating multiple sensing modalities—including five-electrode electrocardiography (ECG), seismocardiography (SCG), and gyrocardiography (GCG)—into a single device with a novel pentaradial configuration featuring five free-standing arms equipped with sensing elements connected to a central electronic hub. The porous material design enhances long-term biocompatibility and user comfort compared to conventional nonporous monitoring devices. The project extends through February 28, 2030, and aims to deliver a high-fidelity cardiac monitoring system capable of recording both electrical and mechanical cardiac signals during daily activities and motion, thereby supporting reliable, continuous ambulatory monitoring for early detection and prevention of life-threatening cardiac events. By minimizing mechanical coupling at the system level and improving device wearability, the developed technology is intended to enhance diagnostic accuracy and patient adherence to continuous cardiac monitoring protocols, ultimately reducing healthcare costs associated with preventable cardiac events.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $598.0k | 3/11/26 |